RHHBY
OTC · Healthcare
Roche Holding AG
$49.74
-1.32 (-2.59%)
RHHBY News30 articles
G7 Leaders Debate AI Model Access Amid OpenAI's $1T IPO Plan and Rising China Competition
G7 leaders debate AI model access as OpenAI files for a $1T IPO. Anthropic restricts models, China boosts local AI, and cybersecurity deals surge.
Outlook Therapeutics Surges on FDA Review of Wet AMD Treatment
Outlook Therapeutics shares jumped 30% after the FDA accepted its resubmitted BLA for ONS-5010/LYTENAVA, setting a PDUFA target date of July 29, 2026.
Roche Shares Inch Up on $2.3B Nurix Deal for Blood Cancer Drug
Roche shares gained 1.07% on a $2.3 billion deal with Nurix for bexobrutideg, a late-stage BTK degrader for CLL, set to enter Phase 3 this summer.
Wall Street Mixed as AI Rally Faces Key Inflation Test
U.S. stocks traded mixed Tuesday as the Dow and S&P 500 posted modest gains while the Nasdaq dipped, with market focus on upcoming inflation data and AI sector strength.
Nurix Surges on Roche's $2.3B Cancer Drug Pact
Nurix shares soared premarket after Roche committed up to $2.3 billion for bexobrutideg, with $700 million upfront, validating the BTK degrader ahead of Phase 3 trials.
Eli Lilly Hits Record Close on Retatrutide Data; Market Awaits Monday
Eli Lilly shares closed at a record $1,131.42 Friday after retatrutide data showed significant reductions in sleep apnea and knee osteoarthritis pain. Investors eye Monday's trade for market reaction.
Oculis Shares Plunge as Eye Drop Fails Key Trial Goal
Oculis shares tumbled 23.4% after two Phase 3 trials of OCS-01 eye drops for diabetic macular edema failed to meet the main vision goal. The company will not pursue U.S. approval for this indication.
FTSE 100 Dips as Oil Breaches $100, Political Uncertainty Weighs
London's FTSE 100 slipped 0.75% on renewed U.S.-Iran tensions pushing oil above $100, while Labour's election losses added political uncertainty. IAG cut its profit outlook on rising fuel costs.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.
Hormuz Crisis Looms Over Oil Markets as Physical Prices Surge
Brent crude slipped to $108.17 on Friday after Iran proposed talks, but the Strait of Hormuz remains disrupted, and physical crude grades trade near $130, signaling further price spikes ahead.
Cue Biopharma Rockets 91% on Allergy Drug License, CEO Change, and $30M Capital Raise
Cue Biopharma shares soared 91.4% after licensing Ascendant-221, a Phase 2 anti-IgE antibody, naming Shao-Lee Lin as CEO, and raising $30 million.
Meta's Q1 Earnings to Gauge AI Investment Payoff Amid Rising Costs
Meta Platforms will announce first-quarter financial results on April 29, as investors assess whether advertising gains can sustain the company's aggressive artificial intelligence investments.
Middle East Turmoil Hits Luxury Watch Sales at Geneva Fair
The Watches and Wonders Geneva fair concluded amid a luxury sector shock, as major brands reported steep sales declines in the Middle East due to regional conflict, impacting Swiss watch exports for a second consecutive year.
Markets Rally on Geopolitical Hopes; AI and Growth ETFs Advised for Young Investors
Equities advanced on optimism for a resolution to the Iran conflict, while a market veteran recommends young investors allocate monthly funds to Vanguard's VGT and VUG ETFs for long-term growth.
Hologic Completes $17.3B Private Equity Buyout, Almeida Named CEO
Blackstone and TPG have closed their $17.3 billion acquisition of Hologic, taking the company private. José Almeida succeeds Steve MacMillan as CEO, with former shareholders receiving $76 per share plus potential earnout.
Intel Buys Back $14.2B Stake in Irish Fab, Bolstering AI Strategy Ahead of Earnings
Intel has regained full ownership of its Fab 34 facility in Ireland through a $14.2 billion buyback of Apollo's stake. The move strengthens Intel's manufacturing control as it prepares to report quarterly results and advance its AI initiatives.
Hologic CEO to Depart as $18.3B Private Equity Acquisition Nears Completion
Hologic announced CEO Steve MacMillan will step down once the company's $18.3 billion acquisition by Blackstone and TPG finalizes, expected around April 7. The deal will take the women's health technology firm private.
Pfizer Shares Reach New Peak Amid Divergent Views on Future Growth
Pfizer shares surged to a 52-week high of $28.30, driven by robust quarterly results and promising oncology data. Analysts remain divided on whether the stock's rally is sustainable given looming growth challenges.
IBM's AI Strategy Under Scrutiny as Q1 Report Looms Amid Stock Slump
IBM shares are trading nearly 27% below their 52-week peak, with pressure mounting on its AI strategy ahead of first-quarter results on April 22. The company recently completed its $11 billion acquisition of Confluent.
EU Gas Prices Hold Near €54 as Supply Fears Mount Ahead of Winter
European benchmark gas prices remain elevated near €54 per megawatt-hour as EU ministers plan emergency talks. Storage levels are critically low at 28%, with Germany reporting higher inflation driven by energy costs.
AST SpaceMobile Targets April 10 for BlueBird 7 Launch Amid Rival Rocket Lab's ESA Milestone
AST SpaceMobile has scheduled its BlueBird 7 satellite launch for April 10, while Rocket Lab successfully completed its first dedicated mission for the European Space Agency. Both companies are advancing amid a backdrop of robust financial results and industry momentum.
BP Shares Slide as Crude Plunge Erases Refinery Sale Gains
BP shares declined 4.2% in London trading after Brent crude prices fell 10.9% to $99.94 per barrel. The drop offset recent gains driven by the company's refinery sale and cost-cutting initiatives.
Indian Markets Rebound Sharply on Easing Oil Prices and IT Rally
Indian equity indices staged a strong recovery on March 20, 2026, with the Sensex jumping 891 points. The rally was fueled by falling crude oil prices and a surge in IT stocks.
Markets Mixed as Bitcoin Soars, Texas Emerges as Financial Hub
Global markets showed divergent trends with Bitcoin climbing above $75,000 as a digital safe haven, while Indian equities recovered strongly. Texas solidified its position as a major financial center with new exchange launches.
Iran Conflict Fuels Global Inflation Surge as Oil Tops $100
The Iran conflict has triggered a severe oil supply disruption, pushing Brent crude above $100 a barrel and sending shockwaves through global freight, agriculture, and consumer markets.
India Races to Secure LPG Amid Gulf War Disruption, Sparks Induction Stove Rush
India has invoked emergency powers to redirect LPG supplies from commercial to residential users following Gulf war disruptions, causing restaurants to limit hot meals and triggering a massive spike in induction cooker purchases.
FTSE 100 Retreats on Oil Spike, Rate Cut Hopes Dim
London's FTSE 100 declined 0.7% in early Thursday trading as Brent crude surged past $100 a barrel, dampening expectations for near-term Bank of England rate cuts and pressuring consumer-focused sectors.
BAE Systems Shares Dip Amid European Defense Sector Sell-Off
BAE Systems' stock declined alongside a broader drop in European defense shares after Rheinmetall's sales forecast disappointed. The company reported a record order backlog and continues its share repurchase program.
AbbVie's Early Obesity Drug Trial Shows Promising Weight Loss Results
AbbVie reported its amylin-based obesity candidate ABBV-295 led to significant weight reduction in an early study, with no serious safety issues observed. The data marks a strategic step for the company as it seeks growth beyond immunology.
Middle East Conflict Sparks Historic Oil Price Surge, Strains Global Supply
Oil prices surged dramatically on Monday, with Brent crude briefly exceeding $119 per barrel, following supply disruptions in the Middle East linked to regional conflict. Governments and companies scrambled to respond to the market shock.